A5518412
Mercaptopurine (6-MP) , ≥99% , 50-44-2
CAS NO.：50-44-2
Empirical Formula: C5H4N4S
Molecular Weight: 152.18
MDL number: MFCD00599524
EINECS: 200-037-4
| Pack Size | Price | Stock | Quantity |
| 50MG | RMB31.20 | In Stock |
|
| 250MG | RMB39.20 | In Stock |
|
| 1G | RMB73.60 | In Stock |
|
| 5g | RMB226.40 | In Stock |
|
| 25g | RMB580.00 | In Stock |
|
| 100g | RMB2102.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 241-244°C |
| Boiling point: | 498.6±37.0 °C(Predicted) |
| Density | 1.463 (estimate) |
| refractive index | 1.5605 (estimate) |
| storage temp. | Inert atmosphere,2-8°C |
| solubility | DMSO : 35.71 mg/mL (234.66 mM; Need ultrasonic) |
| form | solid |
| pka | 7.77, 11.17(at 25℃) |
| color | Light yellow to yellow |
| Water Solubility | 124mg/L(25 ºC) |
| CAS DataBase Reference | 50-44-2(CAS DataBase Reference) |
| IARC | 3 (Vol. 26, Sup 7) 1987 |
| EPA Substance Registry System | Mercaptopurine (50-44-2) |
Description and Uses
6-Mercaptopurine (6-MP) is a antineoplastic, immonusupressant; inhibits purine nucleotide synthesis and metabolism. 6-MP have been used for several decades in the treatment of leukemia and certain other neoplastic diseases. 6-Mercaptopurine is used for maintenance therapy of acute lymphocytic and acute myelogenous leukemia.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
| RIDADR | 3249 |
| HazardClass | 6.1(b) |
| PackingGroup | III |
| HS Code | 2933599590 |
| Hazardous Substances Data | 50-44-2(Hazardous Substances Data) |
| Toxicity | LD50 oral in rat: 277mg/kg |
| Limited Quantities | 5.0 L (1.3 gallons) (liquid) or 5.0 kg (11 lbs) (solid) |
| Excepted Quantities | Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L) |
